# OnCo record generate-biomedicines (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/generate-biomedicines/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "generate-biomedicines" ;
  schema:name "Generate:Biomedicines"@en ;
  schema:description "Generative-AI protein design company (Flagship) that went public in 2026 and is testing an antibody that neutralises leaked ADC payload to reduce side effects."@en ;
  schema:url <https://onco.cc/companies/generate-biomedicines/>, <https://generatebiomedicines.com> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:citation <https://www.biospace.com/press-releases/generate-biomedicines-inc-reports-second-quarter-2026-financial-results-and-provides-business-update> ;
  onco:tag "frontier" ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/urothelial/>, <https://onco.cc/cancers/ovarian/> ;
  onco:sections <https://onco.cc/fronts/ai-computation/>, <https://onco.cc/fronts/adcs/>, <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/ai-drug-design/>, <https://onco.cc/technologies/adc-payload-neutralizer/>, <https://onco.cc/technologies/car-t/> ;
  onco:drugs <https://onco.cc/drugs/enfortumab-vedotin/> ;
  onco:institutions <https://onco.cc/institutions/roswell-park/> .